Biontech SE balance sheet

At the end of fiscal 2025, Biontech SE had total assets of $25.81bn, total liabilities of $3.24bn and shareholders' equity of $22.56bn. It held $9.01bn in cash against $0 of debt: net cash of $9.01bn.

Balance sheet

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Biontech SE: balance sheet, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	0.2	0.5	0.6	1.5	1.9	14.8	12.9	10.1	9.0
Receivables	—	—	—	0.2	14.0	7.6	2.4	1.5	1.1
Inventory	—	0.0	0.0	0.1	0.6	0.5	0.4	0.3	0.1
Total current assets	—	0.5	0.6	2.0	17.1	23.5	21.6	19.5	18.9
Goodwill	—	—	0.0	0.1	0.1	0.1	0.4	0.4	0.4
Total assets	—	0.7	0.9	2.8	17.9	24.9	25.4	23.3	25.8
Total current liabilities	—	0.1	0.2	0.7	3.9	3.2	2.3	2.6	2.5
Short-term debt	—	—	0.0	0.0	0.1	—	—	—	—
Long-term debt	—	—	0.1	0.3	0.2	—	—	—	—
Total debt	0.0	0.0	0.1	0.3	0.3	—	0.0	0.0	0.0
Total liabilities	—	0.4	0.3	1.2	4.5	3.4	3.1	3.2	3.2
Shareholders' equity	−0.1	0.3	0.6	1.7	13.5	21.5	22.4	20.1	22.6
Net debt (negative = net cash)	−0.2	−0.5	−0.5	−1.2	−1.6	−14.8	−12.9	−10.1	−9.0
Shares outstanding	—	—	—	—	243m	243m	238m	240m	251m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BNTX vs UTHR BMRN vs BNTX BNTX vs NBIX BNTX vs NTRA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Biontech SE's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biontech SE.